Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corona RemediesBOM:544644 +0.73%18 Dividend Payout Ratio is 1.02 as of Jun. 2026. GuruFocus rates BOM:544644 with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 448 Drug Manufacturers companies, Corona Remedies ranks worse than 50.22% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Corona Remedies's Dividend Payout Ratio for the
months ended in Jun. 2026 was 1.02.
The historical rank and industry rank for Corona Remedies's Dividend Payout Ratio or its related term are showing as below:
BOM:544644'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.38
Current: 0.38
During the past 4 years, the highest Dividend Payout Ratio of Corona Remedies was 0.38. The lowest was 0.00. And the median was 0.00.
BOM:544644's Dividend Payout Ratio is ranked worse than 50.22% of 448
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs BOM:544644: 0.38
Corona Remedies (BOM:544644) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Corona Remedies Dividend Payout Ratio Related Terms
Corona Remedies Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Corona Remedies's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544644 vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison
For the Drug Manufacturers - General subindustry, Corona Remedies's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corona Remedies Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Corona Remedies's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Corona Remedies's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Corona Remedies's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corona Remedies (BOM:544644) has a Dividend Payout Ratio of 1.02 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Corona Remedies and its competitors. According to the industry distribution chart, Corona Remedies ranks #225 out of 448 companies in the Drug Manufacturers industry, placing it in the top 50.2%.
Is Corona Remedies' Dividend Payout Ratio too high?
Corona Remedies' current Dividend Payout Ratio is 1.02. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Corona Remedies' value of 1.02 is 172% above this industry median. Based on the distribution chart, Corona Remedies ranks #225 out of 448 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Corona Remedies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Corona Remedies' Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Corona Remedies ranks #225 out of 448 companies for Dividend Payout Ratio. This places Corona Remedies in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Corona Remedies' value of 1.02 is 172% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 448 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corona Remedies's current Dividend Payout Ratio of 1.02 is 172% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Corona Remedies and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corona Remedies's current Dividend Payout Ratio is 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corona Remedies stock overvalued right now?
Corona Remedies (BOM:544644) has a current Dividend Payout Ratio of 1.02. The current Dividend Payout Ratio is 1.02 and 172% above the Drug Manufacturers industry median of 0.38. Corona Remedies' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Corona Remedies (BOM:544644), the current Dividend Payout Ratio is 1.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Corona Remedies Ltd is mainly engaged in the business of manufacturing, trading and marketing of Pharmaceutical products. It is engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabetes, pain management, urology and other segments, such as Vitamin Minerals and Nutrients(VMN), gastrointestinal and respiratory therapies. The company's brands are B-29, myoril, Tricium, Cortel, and Obimet. The Company has only one reportable business segment i.e. Pharmaceuticals. The company has presence in India as well as Outside India. The company generates majority of revenue from India.
18GF Score
Get the complete analysis for BOM:544644
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544644 has been successfully added to your 
